Doliprane pediatric: alert to defective pipettes

Doliprane pediatric: alert to defective pipettes
Doliprane pediatric: alert to defective pipettes

the essential
The National Agency for the Safety of Medicines and Health Products (ANSM) reports the existence of a batch of defective pipettes in boxes of Doliprane 2.4%, oral suspension for infants and children produced by the Opella Healthcare France laboratory. .

The National Agency for the Safety of Medicines and Health Products (ANSM) warns of a manufacturing incident that occurred on a series of defective pipettes which usually accompany bottles of Doliprane 2.4% oral suspension intended for infants and children produced by the Opella Healthcare France laboratory.

The laboratory itself alerted the ANSM this Wednesday about this anomaly which concerns the absence of graduation “on only around thirty pipettes”, Opella Healthcare France indicated to the health authorities, specifying that the reported defect only concerns the accessory intended to take the right dose of Doliprane 2.4%, oral suspension to give it to infants and children, but not the medicine itself. “The integrity and quality of the syrup contained in the bottle are intact,” underlines the ANSM, indicating what action to take if you discover that you have a defective box.

Risk of overdose

“If you have a box of Doliprane 2.4%, oral suspension, check that the pipette is correctly graduated. If this is not the case, return the box to a pharmacy, it will be exchanged for you. Do not use the non-graduated pipette or the pipette of another medication,” advises the Medicines Agency, warning of a risk of dosing error. To date, no pharmacovigilance cases related to this printing defect have been reported to the health authorities. The pipette manufacturer claims to have taken measures to ensure that new batches do not contain this defect.

-

-

PREV The number of smokers remains stable, but that of vapers is exploding
NEXT How to improve your brain functions and strengthen your mind? According to neuroscience, you just need to adopt this habit!